Research and
education
deserve attention.

Which is just
what we create.

 
Latest news from Facebook Facebook

23.08.19

PR&D - Public Relations für Forschung & Bildung

SPRAY YOUR PAPERThe new paper of the Ameres Lab made it to the cover story of the current issue of the Journal Molecular Cell! Co-first author Veronika Herzog, IMBA group leader Stefan Ameres and graphic artist Tibor Kulczar are the creatives minds behind the cover artwork. This is to give you a glimpse on the making-of process!
Read more about the paper: bit.ly/2YdtUmq
... See MoreSee Less

SPRAY YOUR PAPERImage attachment
Upcoming Events

AM PULS Nr. 64

Designer Babies, Mammoths & Co. –

The Possibilities of Synthetic Biology

 

(in German only)

 

ap-schriftzug

Wednesday, 3th April 2019 • 6 pm

Kunden-News

15. May 2019

Marinomed Biotech AG: Budesolv with a strongly decreased dose of the active ingredient compared to the marketed product Rhinocort Aqua shows pronounced efficacy already after first application – clinical validation of the Marinosolv® platform:

The pivotal phase III study for Budesolv has provided Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, with clinical validation of the efficacy of its innovative Marinosolv® technology platform.

News lesen

Kunden-News

23. April 2019

AD HOC ANNOUNCEMENT Marinomed Biotech AG announces top line results of the Phase III study for Budesolv:

Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, has announced the successful completion of the pivotal Phase III study for Budesolv. The top line results are now available and show that Budesolv achieves at least the same effect as the product which is currently on the market, with a significantly lower dose.

News lesen

Kunden-News

11. April 2019

Health centres for the homeless: evaluation requires trust:

Trust is a vital factor when it comes to evaluating health centres for socially disadvantaged people. This is a basic recommendation of the Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) in Vienna (Austria), which has published the results of a large-scale international study of this topic.

News lesen

Kunden-News

26. February 2019

Marinomed receives EUR 15m EIB financing:

The European Investment Bank (EIB) is providing EUR 15m to Marinomed Biotech AG, a Vienna- based biopharmaceutical company developing innovative therapies for allergy, respiratory and eye diseases

News lesen